Tranzactioneaza Morphosys Ag (DE.MOR) - 67.9 EUR (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 67.30 EUR
Ask 68.75 EUR
Minim 67.90 EUR
Maxim 67.90 EUR
Pret referinta 67.90
Volum -
Volum ultima zi 1
Max 52 sapt 69.75 EUR
Min 52 sapt 14.72 EUR

Descriere companie

MorphoSys AG (www.morphosys.com/) develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. The Company develops new treatments for patients suffering from serious diseases. Its technologies include HuCAL, which is a collection fully human antibodies and a system for their optimization; Ylanthia, which is an antibody library in Fab format, and Slonomics, an automated technology for gene synthesis and modification for the generation of gene libraries in a controlled process.

Informatii companie

Nume

MORPHOSYS AG O.N.